A prospective study of medication errors arising out of look-alike and sound-alike brand names confusion

International Journal of Risk and Safety in Medicine

Volumn 19, Issue 4, 2007, Pages 195-201

  Joshi, M C ^a   Joshi, H S ^b   Tariq, K ^a   Ejaj, A ^a   Prayag, S ^a   Raju, A ^a  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALFACALCIDOL; ALPRAX; ALPRAZOLAM; AMLODIPINE PLUS LOSARTAN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ATENOLOL; BETA; BETALOC H; CARDACE; CARDACE H; CEFOTAXIME; CEFTRIAXONE; CIPLOX; CIPLOX TZ; CISPLATIN; CLAVIX; CLAVIX AS; CLOPITAB; CLOPITAB AS; COMBIFLAM; COMBUNEX; COMBUTOL; CONTIFLO; CYTOBLASTIN; CYTOPLATIN; DEPLATT; DEPLATT A; ETHAMBUTOL; ETHAMBUTOL PLUS ISONIAZID; FAMCICLOVIR; FLUCONAZOLE; FOLIC ACID; FOLTENE; GABANEURON; GABAPENTIN; GABAPIN; GARDIAN; GENERIC DRUG; GLIMEPIRIDE; GLIMEPIRIDE PLUS METFORMIN; HYDROCORTISONE; LAMIVIR; LORAM; LORAZEPAM; LOSAR; LOSAR A; LOSARTAN; LYCORED; LYCORTIN S; MEBENDAZOLE; METOCLOPRAMIDE; METOCLOPRAMIDE PLUS PARACETAMOL; METOLAR; METOPAR; METOPROLOL; MOBIZOX; NORADRENALIN; NOVAMOX AX; NOVAMOX LB; NUTROLIN B PED; NUTROLIN B PLUS; OFLOXACIN; OFRAMAX; OMNATAX; PIPERACILLIN; R CIN; R CINEX; RIFINEX; STAMLO; TAMSULOSIN; TAZIN; TEICOPLANIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VIZYL; VIZYLAC; ZANOCIN; ZOCON; ZORYL; ZORYL M;

ARTICLE; CONFUSION; DRUG FORMULARY; DRUG LABELING; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INDIA; MEDICATION ERROR; PROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT;

EID: 36549019029     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. J.K. Aronson, Confusion over similar drug names, Problems and solutions, Drug Saf. 12 (1995), 155-160.
2. D.W. Bates and J.M. Teich, Effects of computerized physician order entry on prescribing practices, Arch. Intern. Med. 160 (2000), 2741-2747.
3. B.E. Fortescue, Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients, Pediatrics 111 (2003), 722-729.
4. A. Hazra, Confusing brand names, Indian J. Pharmacol. 34 (2002), 367-368.
5. J.M. Hoffman and S.M. Proulx, Medication errors caused by confusion of drug names, Drug Saf. 26 (2003), 445-452.
6. Indian Drug Review, Mediworld Publication, New Delhi, 2005.
7. Joint Commission on Accreditation of Healthcare Organization, Sentinel Event Alert 19 (2001).
8. B.G. Katona and P.R. Ayd, Effect of pharmacists and nurses interventions on cost of drug therapy in a medical intensive-care unit, Am. J. Hosp. Pharm. 46 (1989), 1179-1182.
9. B.L. Lambert, Predicting look-alike and sound-alike medication errors, Am. J. Health - Syst. Ph. 54 (1997), 1161-1171.
10. B.L. Lambert and S.J. Lin, Similarity as a risk factor in drug-name confusion errors: The look-alike (orthographic) and sound-alike (phonetic) model, Med. Care 37 (1999), 1214-1225.
11. L.L. Leape and D.J. Cullen, Pharmacist participation on physicians rounds and adverse drug events in the intensive care unit, JAMA 282 (1999), 267-270.
12. National Coordinating Council for Medication Error Reporting and Prevention, About medication errors, Available at www.nccmerp.org, 2004.
13. C. Rados, Drug name confusion: Preventing medication errors, FDA Consumer Magazine, 2005.
14. P.V. Rataboli and A. Garg, Confusing brand names: Nightmare of medical profession, J. Postgrad. Med. 51 (2005), 13-16.
15. C.E. Seeley and D. Nicewander, A baseline study of medication error rates at Baylor University Medical Center in preparation for implementation of a computerized physician order entry system, Proc. (Bayl. Univ. Med. Cent.) 17 (2004), 357-361.